NEWS: SEPTEMBER 2005

-09/16/2005-

Genzyme Corp. and Schering AG halt Campath Phase II clinical trials for multiple sclerosis due to the death of a patient from abnormal bleeding. To read article click here.

ACADIA Pharmaceuticals opens new chemistry R&D facility in Sweden. To read article click here.

-09/15/2005-

Genzyme Corp. begins clinical trials of Myozyme® (alglucosidase alfa) for late-onset Pompe disease. To read article click here.

Adolor Corporation initiates Phase II clinical trials of 29CL227 for the treatment of post-surgical incisional pain. To read article click here.

-09/14/2005-

MedImmune Inc. acquires Cellective Therapeutics Inc. To read article click here.

Medicure Inc.'s MC-4232 meets endpoint in Phase II clinical trials for diabteic hypertension. To read article click here.

Merck and FoxHollow Technologies form pharmacogenomics collaboration. To read article click here.

Synta Pharmaceuticals begins Phase IIb clinical trials of STA-5326, and oral IL-12 and IL-23 inhibitor, for Crohn's Disease. To read article click here.

ChemDiv Inc. and Schering AG form medicinal chemitry research collaboration. To read article click here.

Pfizer Inc. completes the acquisition of Vicuron Pharmaceuticals Inc. To read article click here.

-09/13/2005-

FDA advisory panel recommends approval of Tarceva® for the treatement of pancreatic cancer. To read article click here.

Novogen's Phase Ib clinical trials of trans NV-04 for cardiovascular complications show good results. To read article click here.

Angiotech Pharmaceuticals Inc. acquires Afmedica Inc. To read article click here.

Avalon Pharmaceuticals Inc. and Novartis form small molecule research collaboration. To read article click here.

CuraGen Corporation and TopoTarget A/S initiate Phase Ib clinical trials of PXD101 for ovarian cancer treatment. To read article click here.

Evotec Technologies GmbH and Genedata AG form partnership to provide solutions for lead discovery research. To read article click here.

-09/12/2005-

Kosan Biosciences Inc. and the National Cancer Institute (NCI) to delay further clinical trials of 17-AAG for cancer. To read article click here.

Takeda's drug ACTOS® (pioglitazone HCl) shows a reduction of heart attacks, strokes and deaths in Type 2 Diabetes patients. To read article click here.

-09/09/2005-

Voyager Pharmaceutical Corporation goes IPO. To read article click here.

-09/08/2005-

Biogen to lay off 650 employees and plans to sell its rights to its psorasis drug Amevive. To read article click here.

MedImmune Inc. and VasGene Therapeutics form monoclonal antibody research collaboration. To read article click here.

FDA approves the inhaled-insuline drug Exubera® for the treatment Type 1 and Type 2 diabetes in adults. To read article click here.

Caliper Life Sciences Inc. to acquire NovaScreen Biosciences Corporation. To read article click here.

-09/07/2005-

Press Release: Frost & Sullivan: Cost Issues Compel Pharmaceutical Companies to Make Drug Development More Financially Viable. To read press release click here.

GlaxoSmithKline aquires ID Biomedical Corp. for about $1.4 billion. To read article click here.

Novo Nordisk A/S and Sangamo BioSciences Inc. form protein research collaboration. To read article click here.

Novartis and Alnylam Pharmaceuticals Inc. form RNAi research collaboration. To read article click here.

Wyeth opens world's largest integrated biotech production facility. To read article click here.

-09/06/2005-

ViroLogic Inc. changes its name to Monogram Biosciences Inc. To read article click here.

Kinex Pharmaceuticals selects Src kinase inhibitor KX2-377 as a lead drug candidate for clinical development. To read article click here.

-09/05/2005-

Chiron Corp. rejects $4.5 billion all-cash takeover bid made by Novartis AG. To read article click here.

Press Release: Genevac Ltd., world leader in solvent removal technologies, has chosen the forthcoming International Biotech & Lab Automation Europe (IBLA) 2005 meeting for the global launch of a new and greatly enhanced version of its popular EZ-2 centrifugal evaporator. To read press release click here.

Press Release: Frost & Sullivan: Biogenerics Market Poised for Launch as Blockbuster Patents Expire. To read press release click here.

-09/02/2005-

SGX Pharmaceuticals Inc. goes public. To read article click here.

Anika Therapeutics Inc. terminates alliance with Ortho-McNeil Pharmaceuticals. To read article click here.

-09/01/2005-

Novartis AG places $4.5 billion all-cash takeover bid to acquire Chiron Corp. To read article click here.

Press Release: KINEMATIC AND CHEMAXON ANNOUNCE STRATEGIC PARTNERSHIP AND SUCCESSFUL IMPLEMENTATION OF CHEMINFORMATICS CAPABILITIES INTO ENOVATOR. To read press release click here.

Press Release: Frost & Sullivan: Cost-effective R&D Outsourcing Attracts Global Pharmaceutical Industry to India and China.. To read press release click here.